Olumiant 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F3FY7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $68,944
Award facts
- Contract value 100% obligated
- $68,943.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $68,943.77 to AmerisourceBergen Drug Corp for the supply of Olumiant (baricitinib) 4 mg tablets in a quantity of 30 units. Issued on January 27, 2026, with an ultimate completion date of January 28, 2026, this firm fixed-price contract represents a competitive award with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical distribution operations.
This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2031), which serves as the primary vehicle for supplying pharmaceutical products and medical commodities to military healthcare programs globally. Olumiant is a prescription medication used in the treatment of rheumatoid arthritis and other autoimmune conditions, supporting the Defense Logistics Agency's mission to fulfill critical pharmaceutical needs across the military healthcare system. As a major pharmaceutical distributor, AmerisourceBergen demonstrates consistent capability to meet federal procurement requirements through open competition for both routine and specialized medical products.
Quick answers
Who was awarded contract SPE2DR26F3FY7?
SPE2DR26F3FY7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F3FY7 worth?
The government has obligated $68,944 on SPE2DR26F3FY7.
Is contract SPE2DR26F3FY7 an order under another contract?
Yes. SPE2DR26F3FY7 is a delivery order under SPE2DR25D3017, an indefinite delivery contract.
Was contract SPE2DR26F3FY7 competed?
The extent of competition for SPE2DR26F3FY7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award